60 Degrees Pharmaceuticals (60P) has received Fast Track designation from the Food and Drug Administration (FDA) for the investigation of Tafenoquine for prevention of malaria in adults. A drug is designated as a fast track product “for the treatment of a serious or life-threatening disease or condition, and it demonstrates the potential to address unmet…